Progress and Recent Advances in Solid Organ Transplantation

Dear Colleagues,

There have been significant improvements in the short-term survival of solid organ transplantation patients due to advances in immunosuppression and transplant techniques. However, long-term graft survival has lagged behind and now become one of the main problems in solid organ transplantation.

For this Special Issue, we invite researchers and clinicians to submit studies on solid organ transplantation including issues related to donors, allografts, and patient survival following transplantation that will provide us with additional knowledge and skills and help us ultimately to improve outcomes after solid organ transplantation. Original research papers, review articles, and short communications are welcome.

Potential topics include, but are not limited to:

• advances in kidney transplant immunosuppression
• advances in pancreas transplant immunosuppression;
• advances in liver transplantation;
• advances in heart transplantation;
• advances in lung transplantation;
• advances in kidney procurement and transplantation;
• antibody-mediated rejection: new approaches to prevention and management;
• APOL1 genotype and kidney transplantation outcomes;
• BK virus nephropathy and kidney transplantation;
• bone disease after kidney transplantation;
• cardiovascular complications after renal transplantation;
• cell-free DNA and active rejection in solid organ allografts;
• clinical outcomes of kidney transplantation in older end-stage renal disease patients;
• donor-specific antibody and graft outcomes in kidney transplant recipients;
• evaluation of the living kidney donor candidate;
• infectious complications after solid organ transplantation;
• combined liver–kidney transplantation;
• management of acute rejection of solid organ transplant;
• pancreas and kidney transplants;
• pediatric kidney transplantation in the new era;
• post-transplantation diabetes in solid organ transplant recipients;
• post-transplant lymphoproliferative disorder in solid organ transplant recipients;
• recent advances in perioperative management for kidney transplantation;
• recurrent glomerulonephritis after kidney transplantation;
• risks and complications in living kidney donors;
• treatment of chronic antibody-mediated rejection after solid organ transplantation.

Dr. Charat Thongprayoon
Dr. Wisit Cheungpasitporn
Dr. Wisit Kaewput
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.